Publications by authors named "Henry S Friedman"

100Publications

Management of glioblastoma: State of the art and future directions.

CA Cancer J Clin 2020 Jul 1;70(4):299-312. Epub 2020 Jun 1.

The Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21613DOI Listing
July 2020

The role of chemotherapy in the treatment of central neurocytoma.

CNS Oncol 2019 11 5;8(3):CNS41. Epub 2019 Nov 5.

Department of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2019-0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880304PMC
November 2019

Second primary cancers in long-term survivors of glioblastoma.

Neurooncol Pract 2019 Sep 4;6(5):386-391. Epub 2019 Feb 4.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npz001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753354PMC
September 2019

Complementary and integrative health interventions and their association with health-related quality of life in the primary brain tumor population.

Complement Ther Clin Pract 2019 Aug 18;36:43-48. Epub 2019 May 18.

Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, DUMC Box 3624, Durham, NC, 27710, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctcp.2019.05.002DOI Listing
August 2019

MGMT: Immunohistochemical Detection in High-Grade Astrocytomas.

J Neuropathol Exp Neurol 2019 01;78(1):57-64

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnen/nly110DOI Listing
January 2019

Adjunctive perampanel for glioma-associated epilepsy.

Epilepsy Behav Case Rep 2018 9;10:114-117. Epub 2018 Oct 9.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, United States of America.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22133232183010
Publisher Site
http://dx.doi.org/10.1016/j.ebcr.2018.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202665PMC
October 2018

Recurrent Glioblastoma Treated with Recombinant Poliovirus.

N Engl J Med 2018 07 26;379(2):150-161. Epub 2018 Jun 26.

From the Departments of Neurosurgery (A.D., M.G., A.H.F., H.S.F., K.B.P., D.R., J.H.S., G.V., D.A., D.D.B.), Biostatistics (J.E.H., F.M.), Surgery (D.P.B., S.N.), and Pathology (W.T.H., R.E.M.) and the Preston Robert Tisch Brain Tumor Center (A.D., M.G., J.E.H., D.P.B., A.H.F., H.S.F., F.M., S.N., K.B.P., D.R., J.H.S., G.V., W.T.H., R.E.M., D.A., D.D.B.), Duke University Medical Center, and Istari Oncology (D.P.B.) - all in Durham, NC; Tempus Labs, Chicago (N.B.); and the School of Medicine, Deakin University, Geelong, VIC, Australia (A.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065102PMC
July 2018

Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.

J Neurooncol 2018 Jul 21;138(3):489-498. Epub 2018 Mar 21.

Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, 3624 DUMC, Baker House, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2832-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999169PMC
July 2018

Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.

J Neurooncol 2018 Apr 21;137(2):349-356. Epub 2017 Dec 21.

Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2724-1DOI Listing
April 2018

Vaccine Therapy, Oncolytic Viruses, and Gliomas.

Oncology (Williston Park) 2016 Mar;30(3):211-8

View Article

Download full-text PDF

Source
March 2016

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

Nature 2015 Mar 11;519(7543):366-9. Epub 2015 Mar 11.

1] Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina 27710, USA [2] Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA [3] Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA [4] Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, USA [5] Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510871PMC
March 2015

Prognostic marker analysis in pediatric intracranial ependymomas.

J Neurooncol 2015 Apr 7;122(2):255-61. Epub 2015 Jan 7.

Department of Pathology, Duke University School of Medicine, DUMC Box 3712, Durham, NC, 27710, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1711-zDOI Listing
April 2015

Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models.

J Neurooncol 2014 Dec 13;120(3):473-81. Epub 2014 Aug 13.

Department of Neurological Surgery, UC Irvine School of Medicine, Sprague Hall, Irvine, CA, 92697, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1579-yDOI Listing
December 2014

Bevacizumab therapy for glioblastoma: a passionate discussion.

CNS Oncol 2014 Jan;3(1):1-3

The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Room 047, Baker House, Trent Drive, DUMC 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.13.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128197PMC
January 2014

Oncolytic polio virotherapy of cancer.

Cancer 2014 Nov 17;120(21):3277-86. Epub 2014 Jun 17.

Department of Surgery, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Division of Neurosurgery Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Department of Molecular Genetics and Microbiology, Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.28862
Publisher Site
http://dx.doi.org/10.1002/cncr.28862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205207PMC
November 2014

Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.

Nat Genet 2014 Jul 1;46(7):726-30. Epub 2014 Jun 1.

Department of Pathology, Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, The Pediatric Brain Tumor Foundation Institute, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073211PMC
July 2014

Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.

Support Care Cancer 2014 Jul 26;22(7):1897-905. Epub 2014 Feb 26.

Department of Surgery, Duke University Health System, Durham, NC, 27710, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-014-2136-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509487PMC
July 2014

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.

Cancer Med 2013 Apr 24;2(2):185-95. Epub 2013 Jan 24.

Preston Robert Tisch Brain Tumor Center at Duke, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.58DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639657PMC
April 2013

Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

J Neurooncol 2012 Aug 26;109(1):63-70. Epub 2012 Apr 26.

Department of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0861-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404217PMC
August 2012

Neuro-oncology: Glioblastoma--community adjusts to new standard of care.

Nat Rev Neurol 2012 Mar 20;8(5):244-6. Epub 2012 Mar 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2012.42DOI Listing
March 2012

Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.

J Neurooncol 2012 Mar 11;107(1):155-64. Epub 2011 Oct 11.

Department of Surgery, The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0722-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616617PMC
March 2012

Everolimus tablets for patients with subependymal giant cell astrocytoma.

Expert Opin Pharmacother 2011 Oct 1;12(14):2265-9. Epub 2011 Aug 1.

Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center, Department of Surgery, Box 3624, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2011.60
Publisher Site
http://dx.doi.org/10.1517/14656566.2011.601742DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389821PMC
October 2011

Bevacizumab and daily temozolomide for recurrent glioblastoma.

Cancer 2012 Mar 26;118(5):1302-12. Epub 2011 Jul 26.

Department of Neurology, Duke University Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26381DOI Listing
March 2012

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

Neuro Oncol 2011 Jun 9;13(6):660-8. Epub 2011 May 9.

Section of Neuropsychology, Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107095PMC
June 2011

Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.

J Neurooncol 2011 Jan 4;101(1):155-9. Epub 2010 Jun 4.

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0239-0DOI Listing
January 2011

Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma.

Mol Cancer Ther 2010 Apr 6;9(4):779-90. Epub 2010 Apr 6.

Medical Center Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0764DOI Listing
April 2010

Bevacizumab fails to treat temporal paraganglioma: discussion and case illustration.

J Neurooncol 2010 Jul 19;98(3):427-30. Epub 2009 Dec 19.

Department of Surgery, Division of Neurosurgery, Duke University Medical Center, 220 Sands Building, Research Drive, Box 3050, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-0091-2DOI Listing
July 2010

A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells.

Cancer Chemother Pharmacol 2009 Oct 12;64(5):1053-8. Epub 2009 Jul 12.

Department of Pathology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-009-1063-0
Publisher Site
http://dx.doi.org/10.1007/s00280-009-1063-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674501PMC
October 2009

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

Cancer 2009 Aug;115(15):3501-11

Department of Surgery, Duke University Medical Center, and The Preston Robert Tisch Brain Tumor Center, South Hospital, Durham, North Carolina. 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24398DOI Listing
August 2009

Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.

J Neurooncol 2009 Oct 5;95(1):129-134. Epub 2009 May 5.

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9911-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837514PMC
October 2009

Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.

J Magn Reson Imaging 2009 May;29(5):1199-205

Duke University Medical Center, Department of Radiology, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.21732DOI Listing
May 2009

Genomic and molecular profiling predicts response to temozolomide in melanoma.

Clin Cancer Res 2009 Jan;15(2):502-10

Department of Surgery, and Duke Institute for Genome Sciences and Policy, Duke University Medical Center and Durham VA Medical Center, Durham, North Carolina 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1916DOI Listing
January 2009

Distress persists in long-term brain tumor survivors with glioblastoma multiforme.

J Cancer Surviv 2008 Dec 29;2(4):269-74. Epub 2008 Oct 29.

Surgery Department, Tug McGraw Research Center, Preston Robert Tisch Brain Tumor Center at Duke, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11764-008-0069
Web Search
http://link.springer.com/10.1007/s11764-008-0069-7
Publisher Site
http://dx.doi.org/10.1007/s11764-008-0069-7DOI Listing
December 2008

Experience with irinotecan for the treatment of malignant glioma.

Neuro Oncol 2009 Feb 10;11(1):80-91. Epub 2008 Sep 10.

The Preston Robert Tisch Brain Tumor Center at Duke, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://academic.oup.com/neuro-oncology/article/11/1/80/10504
Publisher Site
http://dx.doi.org/10.1215/15228517-2008-075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2718962PMC
February 2009